Share
2,272 Posts.
lightbulb Created with Sketch. 835
clock Created with Sketch. 17/02/23
17:00
Share
Originally posted by StevieBuoy:
↑
A few points really caught my. attention and when collated point to a future that is significantly more exciting and optimistic than before this interview aired......Valve in Valve "we are working with the tier 1 of the tier 1 of physicians in this space globally.... as it turns out about 30% of patients are having their first replacement valve FAIL within about 3-8 years.... some physicians say that 40-50% of patients will need a valve in valve replacement..... ONE OF THE HIGHEST PHYSICIANS OUT THERE WHO HAS TALKED ABOUT THIS PUBLICLY SHE SAID THAT THIS (DURAVR) WOULD 100% BE USED FOR EVERY SINGLE PATIENT WHO NEEDED VALVE IN VALVE." Wayne then goes onto comment that if you take that number as 20 or 30% that is $2-3 Billion US in revenue although (my thoughts) if we use the 40-50% figure that some doctors are using that is $4-5 Billion US in revenues. Total Addressable Market "Certainly when we do the incidence prevalence data, then we take a pharma like penetration of that space, then you're looking at a total addressable market of more like $30 Billon US. The current players who I think have not done a great job of penetrating the market.... I personally believe as do a lot of my management that this market is a potentially a lot bigger than the TAM or the current indicators tell us."
Expand
It is interesting considering Edwards say they can’t meet demand, and they have 15,000 employees and 5 manufacturing plants.
